These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27389167)

  • 21. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS.
    Kanno T; Tanaka K; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Hirayama N; Ikeda JE
    Free Radic Biol Med; 2012 Dec; 53(11):2028-42. PubMed ID: 23000247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
    Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
    Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidant Chemicals for Cancer Prevention in Humans.
    Prasad KN
    J Am Coll Nutr; 2016; 35(2):175-84. PubMed ID: 26151600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
    van Muiswinkel FL; Kuiperij HB
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nrf2 in health and disease: current and future clinical implications.
    Al-Sawaf O; Clarner T; Fragoulis A; Kan YW; Pufe T; Streetz K; Wruck CJ
    Clin Sci (Lond); 2015 Dec; 129(12):989-99. PubMed ID: 26386022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of piperlongumine analogues and discovery of nuclear factor erythroid 2-related factor 2 (Nrf2) activators as potential neuroprotective agents.
    Peng S; Zhang B; Meng X; Yao J; Fang J
    J Med Chem; 2015 Jul; 58(13):5242-55. PubMed ID: 26079183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration.
    Milani P; Ambrosi G; Gammoh O; Blandini F; Cereda C
    Oxid Med Cell Longev; 2013; 2013():836760. PubMed ID: 23983902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration.
    Johnson JA; Johnson DA; Kraft AD; Calkins MJ; Jakel RJ; Vargas MR; Chen PC
    Ann N Y Acad Sci; 2008 Dec; 1147():61-9. PubMed ID: 19076431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quercetin Is An Active Agent in Berries against Neurodegenerative Diseases Progression through Modulation of Nrf2/HO1.
    Bayazid AB; Lim BO
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
    Denzer I; Münch G; Friedland K
    Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.
    Lee DH; Gold R; Linker RA
    Int J Mol Sci; 2012; 13(9):11783-11803. PubMed ID: 23109883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NRF2 as a Therapeutic Target in Neurodegenerative Diseases.
    Brandes MS; Gray NE
    ASN Neuro; 2020; 12():1759091419899782. PubMed ID: 31964153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of Nrf2 transcription factor in cellular response to oxidative stress].
    Florczyk U; Łoboda A; Stachurska A; Józkowicz A; Dulak J
    Postepy Biochem; 2010; 56(2):147-55. PubMed ID: 20873109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of Nrf2 signaling in counteracting neurodegenerative diseases.
    Dinkova-Kostova AT; Kostov RV; Kazantsev AG
    FEBS J; 2018 Oct; 285(19):3576-3590. PubMed ID: 29323772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected Targets.
    Basagni F; Di Paolo ML; Cozza G; Dalla Via L; Fagiani F; Lanni C; Rosini M; Minarini A
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nrf2 as a chemoprevention target in gastrointestinal carcinoma].
    Gao P; Tang XW; Wang XJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 41(4):453-63. PubMed ID: 22927084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
    Johnson DA; Johnson JA
    Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.
    Hybertson BM; Gao B; Bose SK; McCord JM
    Mol Aspects Med; 2011 Aug; 32(4-6):234-46. PubMed ID: 22020111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor-1 inhibits 6-hydroxydopamine-mediated endoplasmic reticulum stress-induced apoptosis via regulation of heme oxygenase-1 and Nrf2 expression in PC12 cells.
    Kim Y; Li E; Park S
    Int J Neurosci; 2012 Nov; 122(11):641-9. PubMed ID: 22703470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activating or Inhibiting Nrf2?
    Chu XY; Liu YM; Zhang HY
    Trends Pharmacol Sci; 2017 Nov; 38(11):953-955. PubMed ID: 28886953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.